Puma Exploration Provides Update on Transactions with Raptor Resources
RIMOUSKI, Quebec, July 02, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is […]
TSX News -
Gibson Energy Appoints Curtis Philippon as New President and Chief Executive Officer
CALGARY, Alberta, July 02, 2024 (GLOBE NEWSWIRE) — Gibson Energy Inc. (“Gibson” or the “Company”) is pleased to announce today […]
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than […]
MariMed Announces Approval of Adult-Use Sales At Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and Maryland
NORWOOD, Mass., July 02, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator […]
WalkMe Celebrates Winners of Annual Realizer Awards
SAN FRANCISCO, July 02, 2024 (GLOBE NEWSWIRE) — WalkMe (NASDAQ: WKME), a leading provider of digital adoption solutions for effectively […]
Jeffs’ Brands Enters Into a LOI for Exclusive Distribution of its Pest Control Solutions in the Gulf States, Including the United Arab Emirates
Tel Aviv, Israel, July 02, 2024 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), […]
Mainz Biomed Provides Half Year 2024 Corporate Update
BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic […]
Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study
DALLAS, July 02, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence […]
Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology […]
Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
Buntanetap showed dose-dependent and statistically significant improvements in cognition in the overall enrolled PD population. Parkinson’s patients with substantial cognitive […]
